Manuela Ferracin (M Ferracin)

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 44

Top Venues

Non-coding RNA

Cancers

Cell death & disease

Nature communications

University of Bologna

University of Ferrara (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Bologna Jan 07 2019

Italy

Professor of Pathology :: Dept of Experimental, Diagnostic and Specialty Medicine - DIMES

University of Bologna Jan 07 2016 - Jan 06 2019

Italy

Assistant professor :: DIMES

Education History

University of Ferrara Jan 01 2004 - Mar 05 2007

Italy

PHD

University of Bologna Oct 01 1997 - Feb 21 2003

Italy

MSC

Publications

Francesca Carosi, Elisabetta Broseghini, Laura Fabbri, Giacomo Corradi, Riccardo Gili, Valentina Forte, Roberta Roncarati, Daria Maria Filippini, Manuela Ferracin
Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives. Cancers 16 (15) (2024)
Maria Naddeo, Elisabetta Broseghini, Federico Venturi, Sabina Vaccari, Barbara Corti, Martina Lambertini, Costantino Ricci, Beatrice Fontana, Giorgio Durante, Milena Pariali, Biagio Scotti, Giulia Milani, Elena Campione, Manuela Ferracin, Emi Dika
Association of miR-146a-5p and miR-21-5p with Prognostic Features in Melanomas. Cancers 16 (9) (2024)
Maria Naddeo, Elisabetta Broseghini, Federico Venturi, Sabina Vaccari, Barbara Corti, Martina Lambertini, Costantino Ricci, Beatrice Fontana, Giorgio Durante, Milena Pariali, Biagio Scotti, Giulia Milani, Elena Campione, Manuela Ferracin, Emi Dika
Association of miR-146a-5p and miR-21-5p with Prognostic Features in Melanomas. Cancers 16 (9) (2024)
Francesca Carosi, Elisabetta Broseghini, Laura Fabbri, Giacomo Corradi, Riccardo Gili, Valentina Forte, Roberta Roncarati, Daria Maria Filippini, Manuela Ferracin
Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives. Cancers 16 (15) (2024)
Elisabetta Broseghini, Daria Maria Filippini, Laura Fabbri, Roberta Leonardi, Andi Abeshi, Davide Dal Molin, Matteo Fermi, Manuela Ferracin, Ignacio Javier Fernandez
Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review. Non-coding RNA 9 (1) (2023)
Katharina Jonas, Felix Prinz, Manuela Ferracin, Katarina Krajina, Alexander J A Deutsch, Tobias Madl, Beate Rinner, Ondrej Slaby, Christiane Klec, Martin Pichler
MiR-4646-5p Acts as a Tumor-Suppressive Factor in Triple Negative Breast Cancer and Targets the Cholesterol Transport Protein GRAMD1B. Non-coding RNA 10 (1) (2023)
Daria Maria Filippini, Elisabetta Broseghini, Francesca Carosi, Davide Dal Molin, Mattia Riefolo, Laura Fabbri, Andi Abeshi, Ignacio Javier Fernandez, Manuela Ferracin
A Systematic Review of Diagnostic and Prognostic Biomarkers for Head and Neck Cancer of Unknown Primary: An Unmet Clinical Need. Diagnostics (Basel, Switzerland) 13 (8) (2023)
Elisabetta Broseghini, Daria Maria Filippini, Laura Fabbri, Roberta Leonardi, Andi Abeshi, Davide Dal Molin, Matteo Fermi, Manuela Ferracin, Ignacio Javier Fernandez
Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review. Non-coding RNA 9 (1) (2023)
Elisabetta Broseghini, Daria Maria Filippini, Laura Fabbri, Roberta Leonardi, Andi Abeshi, Davide Dal Molin, Matteo Fermi, Manuela Ferracin, Ignacio Javier Fernandez
Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review. Non-coding RNA 9 (1) (2023)
Katharina Jonas, Felix Prinz, Manuela Ferracin, Katarina Krajina, Alexander J A Deutsch, Tobias Madl, Beate Rinner, Ondrej Slaby, Christiane Klec, Martin Pichler
MiR-4646-5p Acts as a Tumor-Suppressive Factor in Triple Negative Breast Cancer and Targets the Cholesterol Transport Protein GRAMD1B. Non-coding RNA 10 (1) (2023)
Daria Maria Filippini, Elisabetta Broseghini, Francesca Carosi, Davide Dal Molin, Mattia Riefolo, Laura Fabbri, Andi Abeshi, Ignacio Javier Fernandez, Manuela Ferracin
A Systematic Review of Diagnostic and Prognostic Biomarkers for Head and Neck Cancer of Unknown Primary: An Unmet Clinical Need. Diagnostics (Basel, Switzerland) 13 (8) (2023)
Elisabetta Broseghini, Daria Maria Filippini, Laura Fabbri, Roberta Leonardi, Andi Abeshi, Davide Dal Molin, Matteo Fermi, Manuela Ferracin, Ignacio Javier Fernandez
Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review. Non-coding RNA 9 (1) (2023)
Andreas Untergasser, Jan Hellemans, Michael W Pfaffl, Jan M Ruijter, Maurice J B van den Hoff, Mihnea P Dragomir, Douglas Adamoski, Sandra Martha Gomes Dias, Rui Manuel Vieira Reis, Manuela Ferracin, Emmanuel Dias-Neto, Ian Marsh, Mikael Kubista, Muller Fabbri, Ajay Goel, Ondřej Slabý, Erik Knutsen, BaoQing Chen, Massimo Negrini, Koshi Mimori, Martin Pichler, Maria Papatriantafyllou, Simone Anfossi, Thomas D Schmittgen, Jim Huggett, Stephen Bustin, Jo Vandesompele, George Adrian Calin, null null
Disclosing quantitative RT-PCR raw data during manuscript submission:a call for action. Molecular oncology (2023)
Katharina Jonas, Felix Prinz, Manuela Ferracin, Katarina Krajina, Alexander J A Deutsch, Tobias Madl, Beate Rinner, Ondrej Slaby, Christiane Klec, Martin Pichler
MiR-4646-5p Acts as a Tumor-Suppressive Factor in Triple Negative Breast Cancer and Targets the Cholesterol Transport Protein GRAMD1B. Non-coding RNA 10 (1) (2023)
Gabriele Donati, Chiara Abenavoli, Gisella Vischini, Giovanna Cenacchi, Roberta Costa, Gianandrea Pasquinelli, Manuela Ferracin, Noemi Laprovitera, Giorgia Comai, Giorgio Monti, Fabrizio Giostra, Gaetano La Manna
Sickle Cell Trait and SARS-CoV-2-Induced Rhabdomyolysis: A Case Report. The American journal of case reports 23 (2022)
Giulia Lombardi, Roberta Valeria Latorre, Alessandro Mosca, Diego Calvanese, Luisa Tomasello, Christian Boni, Manuela Ferracin, Massimo Negrini, Nader Al Dewik, Mohamad A Yassin, Mohamed A Ismail, Bruno Carpentieri, Claudio Sorio, Paola Lecca
Gene Expression Landscape of Chronic Myeloid Leukemia K562 Cells Overexpressing the Tumor Suppressor Gene PTPRG. International journal of molecular sciences 23 (17) (2022)
Beatrice Maranini, Giovanni Ciancio, Manuela Ferracin, Rosario Cultrera, Massimo Negrini, Silvia Sabbioni, Marcello Govoni
microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review. Life (Basel, Switzerland) 12 (2) (2022)
Giorgio Durante, Francesca Comito, Martina Lambertini, Elisabetta Broseghini, Emi Dika, Manuela Ferracin
Non-coding RNA dysregulation in skin cancers. Essays in biochemistry 65 (4) (2022)
Giorgio Durante, Elisabetta Broseghini, Francesca Comito, Maria Naddeo, Massimo Milani, Irene Salamon, Elena Campione, Emi Dika, Manuela Ferracin
Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer. Expert review of molecular diagnostics 22 (3) (2022)
Stefano Miglietta, Giulia Girolimetti, Lorena Marchio, Manuela Sollazzo, Noemi Laprovitera, Sara Coluccelli, Dario de Biase, Antonio De Leo, Donatella Santini, Ivana Kurelac, Luisa Iommarini, Anna Maria Ghelli, Davide Campana, Manuela Ferracin, Anna Myriam Perrone, Giuseppe Gasparre, Anna Maria Porcelli
MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer. Non-coding RNA 8 (5) (2022)
Irene Salamon, Elena Biagini, Paolo Kunderfranco, Roberta Roncarati, Manuela Ferracin, Nevio Taglieri, Elena Nardi, Noemi Laprovitera, Luciana Tomasi, Marisa Santostefano, Raffaello Ditaranto, Giovanni Vitale, Elena Cavarretta, Antonio Pisani, Eleonora Riccio, Valeria Aiello, Irene Capelli, Gaetano La Manna, Nazzareno Galiè, Letizia Spinelli, Gianluigi Condorelli
Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson-Fabry disease. Cell death & disease 12 (12) (2021)
Noemi Laprovitera, Mattia Riefolo, Elisa Porcellini, Giorgio Durante, Ingrid Garajova, Francesco Vasuri, Ariane Aigelsreiter, Nadia Dandachi, Giuseppe Benvenuto, Federico Agostinis, Silvia Sabbioni, Ioana Berindan Neagoe, Chiara Romualdi, Andrea Ardizzoni, Davide Trerè, Martin Pichler, Antonietta D'Errico, Manuela Ferracin
MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary. Molecular oncology 15 (10) (2021)
Michele Manganelli, Ilaria Grossi, Manuela Ferracin, Paola Guerriero, Massimo Negrini, Michele Ghidini, Chiara Senti, Margherita Ratti, Claudio Pizzo, Rodolfo Passalacqua, Sarah Molfino, Gian Luca Baiocchi, Nazario Portolani, Eleonora Marchina, Giuseppina De Petro, Alessandro Salvi
Longitudinal Circulating Levels of miR-23b-3p, miR-126-3p and lncRNA GAS5 in HCC Patients Treated with Sorafenib. Biomedicines 9 (7) (2021)
Elisabetta Broseghini, Emi Dika, Eric Londin, Manuela Ferracin
MicroRNA Isoforms Contribution to Melanoma Pathogenesis. Non-coding RNA 7 (4) (2021)
Anna Pegoraro, Elena De Marchi, Manuela Ferracin, Elisa Orioli, Michele Zanoni, Cristian Bassi, Anna Tesei, Marina Capece, Emi Dika, Massimo Negrini, Francesco Di Virgilio, Elena Adinolfi
P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells. Cell death & disease 12 (12) (2021)
Emi Dika, Elisabetta Broseghini, Elisa Porcellini, Martina Lambertini, Mattia Riefolo, Giorgio Durante, Phillipe Loher, Roberta Roncarati, Cristian Bassi, Cosimo Misciali, Massimo Negrini, Isidore Rigoutsos, Eric Londin, Annalisa Patrizi, Manuela Ferracin
Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis. Cell death & disease 12 (5) (2021)
Noemi Laprovitera, Mattia Riefolo, Elisa Ambrosini, Christiane Klec, Martin Pichler, Manuela Ferracin
Cancer of Unknown Primary: Challenges and Progress in Clinical Management. Cancers 13 (3) (2021)
Maria Rosaria Sapienza, Giuseppe Benvenuto, Manuela Ferracin, Saveria Mazzara, Fabio Fuligni, Claudio Tripodo, Beatrice Belmonte, Daniele Fanoni, Federica Melle, Giovanna Motta, Valentina Tabanelli, Jessica Consiglio, Vincenzo Mazzara, Marcello Del Corvo, Stefano Fiori, Alessandro Pileri, Gaetano Ivan Dellino, Lorenzo Cerroni, Fabio Facchetti, Emilio Berti, Sabattini Elena, Marco Paulli, Carlo Maria Croce, Stefano A Pileri
Newly-Discovered Neural Features Expand the Pathobiological Knowledge of Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancers 13 (18) (2021)
Neil Renwick, Assam El-Osta, Irene Salamon, Elisabetta Broseghini, Manuela Ferracin, Laura Poliseno, Stanislovas S Jankauskas, Gaetano Santulli, Hua Xiao, Patrick K T Shiu, Souvick Roy, Ajay Goel
The Non-Coding RNA Journal Club: Highlights on Recent Papers-9. Non-coding RNA 7 (3) (2021)
Emanuela Mensa, Michele Guescini, Angelica Giuliani, Maria Giulia Bacalini, Deborah Ramini, Giacomo Corleone, Manuela Ferracin, Gianluca Fulgenzi, Laura Graciotti, Francesco Prattichizzo, Leonardo Sorci, Michela Battistelli, Vladia Monsurrò, Anna Rita Bonfigli, Maurizio Cardelli, Rina Recchioni, Fiorella Marcheselli, Silvia Latini, Serena Maggio, Mirco Fanelli, Stefano Amatori, Gianluca Storci, Antonio Ceriello, Vilberto Stocchi, Maria De Luca, Luca Magnani, Maria Rita Rippo, Antonio Domenico Procopio, Claudia Sala, Iva Budimir, Cristian Bassi, Massimo Negrini, Paolo Garagnani, Claudio Franceschi, Jacopo Sabbatinelli, Massimiliano Bonafè, Fabiola Olivieri
Small extracellular vesicles deliver miR-21 and miR-217 as pro-senescence effectors to endothelial cells. Journal of extracellular vesicles 9 (1) (2020)
Michela Pucci, Inês Gomes Ferreira, Martina Orlandani, Nadia Malagolini, Manuela Ferracin, Fabio Dall'Olio
High Expression of the Sda Synthase B4GALNT2 Associates with Good Prognosis and Attenuates Stemness in Colon Cancer. Cells 9 (4) (2020)
Valeria Barili, Paola Fisicaro, Barbara Montanini, Greta Acerbi, Anita Filippi, Giovanna Forleo, Chiara Romualdi, Manuela Ferracin, Francesca Guerrieri, Giuseppe Pedrazzi, Carolina Boni, Marzia Rossi, Andrea Vecchi, Amalia Penna, Alessandra Zecca, Cristina Mori, Alessandra Orlandini, Elisa Negri, Marco Pesci, Marco Massari, Gabriele Missale, Massimo Levrero, Simone Ottonello, Carlo Ferrari
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection. Nature communications 11 (1) (2020)
Emi Dika, Federica Scarfì, Manuela Ferracin, Elisabetta Broseghini, Emanuela Marcelli, Barbara Bortolani, Elena Campione, Mattia Riefolo, Costantino Ricci, Martina Lambertini
Basal Cell Carcinoma: A Comprehensive Review. International journal of molecular sciences 21 (15) (2020)
Michela Pucci, Inês Gomes Ferreira, Nadia Malagolini, Manuela Ferracin, Fabio Dall'Olio
The Sda Synthase B4GALNT2 Reduces Malignancy and Stemness in Colon Cancer Cell Lines Independently of Sialyl Lewis X Inhibition. International journal of molecular sciences 21 (18) (2020)
Patrizia Nanni, Lorena Landuzzi, Maria Cristina Manara, Alberto Righi, Giordano Nicoletti, Camilla Cristalli, Michela Pasello, Alessandro Parra, Marianna Carrabotta, Manuela Ferracin, Arianna Palladini, Marianna L Ianzano, Veronica Giusti, Francesca Ruzzi, Mauro Magnani, Davide Maria Donati, Piero Picci, Pier-Luigi Lollini, Katia Scotlandi
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations. Scientific reports 9 (1) (2019)
Hua Xiao, Patrick K T Shiu, Marta Gabryleska, Simon J Conn, Abhishek Dey, Kausik Chakrabarti, Manuel Regouc, Martin Pichler, Ulf Andersson Vang Ørom, Joseph H Taube, Satoshi Nishiwada, Ajay Goel, Vaishnavi Nagarajan, Lisa Timmons, Suresh K Alahari, Noemi Laprovitera, Manuela Ferracin, Po Hu, Hailing Jin
The Non-Coding RNA Journal Club: Highlights on Recent Papers-7. Non-coding RNA 5 (2) (2019)
Alessandra De Feo, Marika Sciandra, Manuela Ferracin, Federica Felicetti, Annalisa Astolfi, Ymera Pignochino, Piero Picci, Alessandra Carè, Katia Scotlandi
Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation. Cell death & disease 10 (7) (2019)
Gianluca Storci, Sabrina De Carolis, Alessio Papi, Maria Giulia Bacalini, Noémie Gensous, Elena Marasco, Anna Tesei, Francesco Fabbri, Chiara Arienti, Michele Zanoni, Anna Sarnelli, Spartaco Santi, Fabiola Olivieri, Emanuela Mensà, Silvia Latini, Manuela Ferracin, Stefano Salvioli, Paolo Garagnani, Claudio Franceschi, Massimiliano Bonafè
Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians. Cell death and differentiation 26 (9) (2019)
Marika Cinausero, Noemi Laprovitera, Giovanna De Maglio, Lorenzo Gerratana, Mattia Riefolo, Marianna Macerelli, Michelangelo Fiorentino, Elisa Porcellini, Vanessa Buoro, Francesco Gelsomino, Anna Squadrilli, Gianpiero Fasola, Massimo Negrini, Marcello Tiseo, Manuela Ferracin, Andrea Ardizzoni
KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC. Therapeutic advances in medical oncology 11 (2019)
Emi Dika, Annalisa Patrizi, Martina Lambertini, Nicholas Manuelpillai, Michelangelo Fiorentino, Annalisa Altimari, Manuela Ferracin, Mattia Lauriola, Enrica Fabbri, Elena Campione, Giulia Veronesi, Federica Scarfì
Estrogen Receptors and Melanoma: A Review. Cells 8 (11) (2019)
Ivan Vannini, Petra M Wise, Kishore B Challagundla, Meropi Plousiou, Mirco Raffini, Erika Bandini, Francesca Fanini, Giorgia Paliaga, Melissa Crawford, Manuela Ferracin, Cristina Ivan, Linda Fabris, Ramana V Davuluri, Zhiyi Guo, Maria Angelica Cortez, Xinna Zhang, Lu Chen, Shuxing Zhang, Cecilia Fernandez-Cymering, Leng Han, Silvia Carloni, Samanta Salvi, Hui Ling, Mariam Murtadha, Paolo Neviani, Barbara J Gitlitz, Ite A Laird-Offringa, Patrick Nana-Sinkam, Massimo Negrini, Han Liang, Dino Amadori, Amelia Cimmino, George A Calin, Muller Fabbri
Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nature communications 9 (1) (2018)
Neha Nagpal, Shivani Sharma, Sourobh Maji, Giorgio Durante, Manuela Ferracin, Jitendra K Thakur, Ritu Kulshreshtha
Essential role of MED1 in the transcriptional regulation of ER-dependent oncogenic miRNAs in breast cancer. Scientific reports 8 (1) (2018)
Paola Fisicaro, Valeria Barili, Barbara Montanini, Greta Acerbi, Manuela Ferracin, Francesca Guerrieri, Debora Salerno, Carolina Boni, Marco Massari, M Cristina Cavallo, Glenda Grossi, Tiziana Giuberti, Pietro Lampertico, Gabriele Missale, Massimo Levrero, Simone Ottonello, Carlo Ferrari
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B. Nature medicine 23 (3) (2017)
Ivan Vannini, Petra M Wise, Kishore B Challagundla, Meropi Plousiou, Mirco Raffini, Erika Bandini, Francesca Fanini, Giorgia Paliaga, Melissa Crawford, Manuela Ferracin, Cristina Ivan, Linda Fabris, Ramana V Davuluri, Zhiyi Guo, Maria Angelica Cortez, Xinna Zhang, Lu Chen, Shuxing Zhang, Cecilia Fernandez-Cymering, Leng Han, Silvia Carloni, Samanta Salvi, Hui Ling, Mariam Murtadha, Paolo Neviani, Barbara J Gitlitz, Ite A Laird-Offringa, Patrick Nana-Sinkam, Massimo Negrini, Han Liang, Dino Amadori, Amelia Cimmino, George A Calin, Muller Fabbri
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nature communications 8 (1) (2017)
F Amoroso, M Capece, A Rotondo, D Cangelosi, Manuela Ferracin, A Franceschini, L Raffaghello, V Pistoia, L Varesio, Elena Adinolfi
The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma. Oncogene 34 (41) (2015)
A De Cola, S Volpe, M C Budani, Manuela Ferracin, R Lattanzio, A Turdo, D D'Agostino, E Capone, G Stassi, M Todaro, C Di Ilio, G Sala, M Piantelli, M Negrini, A Veronese, V De Laurenzi
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance. Cell death & disease 6 (2015)
Giovanni Ciancio, Stefania Volpinari, Maria Fotinidi, Federica Furini, Ilaria Farina, Alessandra Bortoluzzi, Manuela Ferracin, Francesca Bandinelli, Carlo Orzincolo, Francesco Trotta, Marcello Govoni
Involvement of the inconstant bursa of the fifth metatarsophalangeal joint in psoriatic arthritis: a clinical and ultrasonographic study. BioMed research international 2014 (2014)

Manuela Ferracin.css-eqlu8i{font-size:small;padding-left:4px;} (M Ferracin)

Publication Activity (10 Years)

Top Topics

Top Venues

Manuela Ferracin (M Ferracin)